Earnings Releases

Getaround, Inc reported the year ended December 31, 2023 results: revenue $72.7 million, net income GAAP Net Loss of $113.9 million.

“focus on cost optimization measures. Throughout the year we also recognized significant benefits from the business restructuring announced in February 2023." ● Total Revenues of $72.7 million, an increase of 22% year-over-year ● Gross Booking Value of $204 million, an increase of 16% year-over-year ● Gross margin from Service revenue was 85%, consistent with the prior”

AEON Biopharma, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023.

“AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON, AEON WS), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex for the treatment of multiple debilitating medical conditions, announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.”

Spectral AI, Inc. reported financial results for the quarter and year ended December 31, 2023.

“On March 27, 2024, Spectral AI, Inc. (the “Company”) reported its financial results for the quarter and year ended December 31, 2023. A copy of the press release containing this information is furnished as Exhibit 99.1 hereto and is incorporated by reference in this Item 2.02.”

SAB Biotherapeutics, Inc. reported the year and quarter ended December 31, 2023 results: net income net loss of $42.2 million.

“SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results”

Vincerx Pharma, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023.

“On March 29, 2024, Vincerx Pharma, Inc. (the “Company”) issued a press release announcing financial results for its fiscal year ended December 31, 2023.”

Unicycive Therapeutics, Inc. reported the year ended December 31, 2023 results: net income Net loss attributable to common stockholders for the year ended December 31, 2023 was $31.4 million, or $1.28 per share.

“Net loss attributable to common stockholders for the year ended December 31, 2023 was $31.4 million, or $1.28 per share of common stock, compared to a net loss of $18.1 million, or $1.20 per share of common stock, for the same period in 2022.”

Vivos Therapeutics, Inc. reported financial results for fourth quarter and full year ended December 31, 2023.

“On March 28, 2024, Vivos Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2023.”

Inmune Bio, Inc. reported the year ended December 31, 2023 results: net income approximately $30.0 million.

“Net loss attributable to common stockholders for the year ended December 31, 2023, was approximately $30.0 million, compared to approximately $27.3 million during the year ended December 31, 2022.”

Iterum Therapeutics plc reported financial results for the fourth quarter and year ended December 31, 2023.

“On March 28, 2024, Iterum Therapeutics plc issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2023.”

iANTHUS CAPITAL HOLDINGS, INC. reported fiscal fourth quarter ended December 31, 2023 results: revenue $40.9 million, net income $18.7 million, EPS less than $0.01 per share.

“Fourth Quarter 2023 Financial Highlights • Revenue of $40.9 million, a sequential decrease of 4.7% from Q3 2023 and an increase of 8.8% from the same quarter in the prior year. • Gross profit of $15.9 million, a sequential increase of 19.3% from Q3 2023 and a decrease of 1.1% from the same quarter in the prior year. • Gross margin of 38.9%, reflecting a sequential increase of 782bps when compared to Q3 2023 and a decrease of 389bps from the same quarter in the prior year. • Net loss of $18.7 million, or a net loss of less than $0.01 per share, compared to a net loss of $19.2 million, or a net loss of less than $0.01 per share in Q3 2023, and compared to a net loss of $43.7 million, or a net loss of $0.01 per share, in the same quarter in the prior year.”

iANTHUS CAPITAL HOLDINGS, INC. reported fiscal year ended December 31, 2023 results: revenue $159.2 million, net income $76.6 million, EPS $0.01 per share.

“2023 Financial Highlights • Revenue of $159.2 million, down 2.4% from the prior year. • Gross profit of $63.2 million, down 15.1% from the prior year. • Gross margin of 39.7%, reflecting a decrease of 5.9% from the prior year. • Net loss of $76.6 million, or a net loss of $0.01 per share, compared to a net loss of $449.4 million, or a net loss of $0.13 per share, in the prior year.”

Elicio Therapeutics, Inc. reported the year ending December 31, 2023 results: net income Net loss for 2023 was $35.2 million, EPS Net loss per share for 2023 was $6.96.

“Elicio Therapeutics, Inc. (the “Company”) announced its financial results for the year ended December 31, 2023 and provided corporate updates.”

Professional Diversity Network, Inc. reported the quarter and fiscal year ended December 31, 2023 results: revenue approximately $ 7,699,000, net income a net loss of approximately $ 4,386,000.

“Professional Diversity Network, Inc. Announces Financial Results for the Quarter and Fiscal Year Ended December 31, 2023”

RANGE IMPACT, INC. reported the fourth quarter and fiscal year ended December 31, 2023 results: revenue $6,877,519 in 4Q 2023 versus $2,645,661 in 4Q 2022, an increase of $4,231,858, and $19,346,306 for the full year 2023 ve, net income ($83,022) in 4Q 2023 versus ($61,400) in 4Q 2022, a decrease of ($21,622), and $3,131,055 for the full year 2023 versus.

“On March 29, 2024, the Company issued a press release reporting its financial results for the fourth quarter and the full year 2023.”

KALA BIO, Inc. reported financial results for the quarter and year ended December 31, 2023.

“On March 29, 2024, KALA BIO, Inc. announced its financial results for the quarter and year ended December 31, 2023 and provided a general business update. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.”

APPIAN CORP updated its first quarter and full year ending December 31, 2024 guidance (reaffirmed).

“The Company is affirming its previously provided guidance for the first quarter and full year ending December 31, 2024, previously provided in its fourth quarter 2023 earnings release and conference call on February 15, 2024.”

Emeren Group Ltd reported 2024 full year results: revenue $150 million - $160 million. Guidance initiated.

“We expect 2024 full year revenue to be in the range of $150 million - $160 million.”

Emeren Group Ltd reported the year ended December 31, 2023 results: revenue $104.7 million, net income $9.3 million.

“We closed 2023 with $104.7 million revenue, 22.2% gross margin and a $9.3 million net loss.”

FITLIFE BRANDS, INC. reported fourth quarter ended December 31, 2023 results: net income $1.5 million.

“Total revenue for the fourth quarter was $13.3 million, an increase of 148% compared to the same period in 2022.”

FITLIFE BRANDS, INC. reported fiscal year ended December 31, 2023 results: net income $5.3 million.

“Total revenue was $52.7 million, an increase of 83% compared to $28.8 million in the prior year.”

Molecular Templates, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023.

“On March 29, 2024, Molecular Templates, Inc. (the "Company") announced its financial results for the fourth quarter and full year ended December 31, 2023.”

GALECTIN THERAPEUTICS INC reported the year ended December 31, 2023 results: net income net loss applicable to common stockholders of $44.8 million, or ($0.74) per share, EPS $(0.74).

“For the year ended December 31, 2023, the Company reported a net loss applicable to common stockholders of $44.8 million, or ($0.74) per share, compared to a net loss applicable to common stockholders of $38.9 million, or ($0.65) per share for the year ended December 31, 2022.”

ASCENT INDUSTRIES CO. reported financial results for fourth quarter and full year ended December 31, 2023.

“On March 28, 2024, Ascent Industries Co. ("the Company") issued a press release announcing financial information for its fourth quarter and fiscal year ended December 31, 2023. The press release is attached as Exhibit 99.1 to this Form 8-K and is furnished to, but not filed with, the Commission.”

ACHIEVE LIFE SCIENCES, INC. reported fourth quarter and year ended December 31, 2023 results: net income $5.5 million and $29.8 million.

“Total net loss for the fourth quarter and year ended December 31, 2023 was $5.5 million and $29.8 million, respectively.”

ENGLOBAL CORP reported the year ended December 30, 2023 results: revenue $39.0 million, net income $15.2 million, EPS $3.03 per fully diluted share.

“Revenues for the year ended December 30, 2023 were $39.0 million, a decrease of $1.2 million from $40.2 million for the year ended December 31, 2022. Net loss for 2023 was $15.2 million compared to net loss of $18.5 million in 2022. ENGlobal lost $3.03 per fully diluted share in 2023 compared to a loss of $4.16 per fully diluted share in 2022.”

UNIVERSAL STAINLESS & ALLOY PRODUCTS INC reported preliminary financial results for the quarter and year ended December 31, 2023.

“On March 28, 2024, Universal Stainless & Alloy Products, Inc. (the “Company”) issued a press release including, among other things, certain preliminary financial information for the Company’s quarter and year ended December 31, 2023.”

Consolidated Water Co. Ltd. reported the year ended December 31, 2023 results: revenue $180.2 million, net income $30.7 million, EPS $1.93 per diluted share.

“Consolidated Water Reports 2023 Revenue up 92% to $180.2 Million, Net Income of $30.7 Million or $1.93 per Diluted Share”

Aspira Women's Health Inc. reported the fourth quarter and year ended December 31, 2023 results: revenue Product revenue was $2.1 million for the three months ended December 31, 2023.

“Aspira Women’s Health Inc. (the “Company”) issued a press release reporting financial results for the three and twelve months ended December 31, 2023.”

SEMTECH CORP reported financial results for fiscal year 2024, which ended January 28, 2024.

“On March 28, 2024, the Registrant issued a press release announcing its financial results for the fourth quarter and fiscal year 2024, which ended January 28, 2024.”

PROGRESS SOFTWARE CORP /MA reported Fiscal first quarter ended February 29, 2024 results: revenue $185 million, EPS $0.51 diluted earnings per share.

“provider of infrastructure software, today announced financial results for its fiscal first quarter ended February 29, 2024. First Quarter 2024 Highlights 1 : • Revenue of $185 million increased 12% year-over-year on both an actual and a constant currency basis. • Non-GAAP revenue of $185 million increased 12% year-over-year on an actual currency basis and 11%”

STRATUS PROPERTIES INC reported year ended December 31, 2023 results: revenue $17,270, net income $(14.8) million, or $(1.85) per diluted share, EPS $(1.85) per diluted share.

“Year Ended December 31, 2023 2022 Revenues Real estate operations $ 2,551 $ 24,750 Leasing operations 14,719 12,754 Eliminations and other — (6) Total consolidated revenue $ 17,270 $ 37,498 Operating (loss) income Real estate operations $ (7,218) $ 164 Leasing operations a 5,410 9,621 Corporate, eliminations and other b (15,138) (17,548) Total consolidated”

PSYCHEMEDICS CORP reported the year ended December 31, 2023 results: revenue $22.1 million, net income net loss of approximately $4.2 million, EPS $0.72 per share.

“but also solidify our position as the leader in the industry,” added Shannon Shoemaker, Chief Revenue Officer. The Company's revenue for the year ended December 31, 2023, was $22.1 million versus $25.2 million for the prior year, a decrease of 12%. As of December 31, 2023, the Company had cash and cash equivalents of approximately $2.0 million, compared with”

CVD EQUIPMENT CORP reported financial results for fourth quarter and fiscal year ended December 31, 2023.

“On March 28, 2024, the Company issued a press release announcing its results of operations for the fourth quarter and fiscal year ended December 31, 2023.”

OXFORD INDUSTRIES INC reported financial results for fourth quarter and the fiscal year ended February 3, 2024.

“On March 28, 2024, Oxford Industries, Inc. issued a press release announcing, among other things, its financial results for the fourth quarter and the fiscal year ended February 3, 2024.”

AMERICAN SHARED HOSPITAL SERVICES reported the fourth quarter ended December 31, 2023 results: revenue $5,698,000, EPS $0.06 per share.

“SAN FRANCISCO, CA, March 27, 2024 ‒ American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced financial results for the fourth quarter ended December 31, 2023. Fourth Quarter 2023 Highlights ● Total revenue in the fourth quarter was $5,698,000, an increase of 13.1% from the comparable period in 2022. Total proton therapy revenue increased 36.0% period-over-period; fractions increased 30.0%. Gamma Knife revenue decreased 5.3% period-over-period; procedures decreased 15.8% due to the expiration of two customer agreements and downtime at two sites for the installation of upgraded equipment. ● Gross margin was $2,816,000, a period-over-period increase of 24.1%. The gross margin percentage was 49.4% of revenue. ● Operating income for the fourth quarter of 2023 was $407,000 compared to operating income of $590,000”

REX AMERICAN RESOURCES Corp reported full fiscal year 2023 results: revenue $833.4 million, net income $60.9 million, EPS $3.47.

“Q4 and Full Fiscal Year ‘23, respectively, an increase of more than 100% over each of the respective periods for 2022 § Reported net sales and revenue of $187.6 million and $833.4 million for Q4 and Full Fiscal Year ’23, respectively, a decrease of approximately 6% and 3% from each of the respective periods for 2022 § Reported consolidated ethanol sales volumes of”

REX AMERICAN RESOURCES Corp reported the three-month period ended January 31, 2024 results: revenue $187.6 million, net income $20.6 million, EPS $1.16.

“and $98.2 million for Q4 and Full Fiscal Year ‘23, respectively, an increase of more than 100% over each of the respective periods for 2022 § Reported net sales and revenue of $187.6 million and $833.4 million for Q4 and Full Fiscal Year ’23, respectively, a decrease of approximately 6% and 3% from each of the respective periods for 2022 § Reported consolidated”

Perspective Therapeutics, Inc. reported financial results for the year ended December 31, 2023.

“On March 28, 2024, Perspective Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the year ended December 31, 2023”

STIFEL FINANCIAL CORP reported preliminary financial results for February 29, 2024.

“Stifel Financial Corp. (NYSE: SF) today reported selected operating results for February 29, 2024”

MAUI LAND & PINEAPPLE CO INC reported financial results for the year ended December 31, 2023.

“On March 28, 2024, the Company issued a press release, which sets forth the results of its operations for the year ended December 31, 2023.”

FULLER H B CO reported first quarter ended March 2, 2024 results: revenue $810 million, net income $31 million, EPS $0.55 per diluted share. Guidance reaffirmed.

“reported financial results for its first quarter that ended March 2, 2024. First Quarter 2024 Noteworthy Items: ■ Net revenue was $810 million, up slightly year-on-year;”

TENAX THERAPEUTICS, INC. reported year ended December 31, 2023 results: net income $7.7 million.

“Tenax Therapeutics reported a net loss for 2023 of $7.7 million”

SUNation Energy, Inc. reported the fourth-quarter and full year ended December 31, 2023 results: revenue $79.6 million.

“transition by helping individual homeowners take control of their electricity production, storage, and consumption. We came in just shy of our revenue guidance range, generating $79.6 million, and more importantly were able to deliver positive adjusted EBITDA over the full year. In 2024, we anticipate interest rates to start to fall, hardware costs to continue to”

Hut 8 Corp. reported six months ended December 31, 2023 results: revenue 60.6 million, net income 6.2 million.

“Revenue of $60.6 million including $12.6 million from Managed Services ​ Net Income of $6.2 million and Adjusted EBITDA of $62.3 million”

ACELYRIN, Inc. reported the full year ended December 31, 2023 results: net income Net loss for the full year ended December 31, 2023 was $381.6 million, compared to $64.8 million for 2022..

“On March 28, 2024, ACELYRIN, INC. (the " Company ") issued a press release announcing its financial results for the year ended December 31, 2023.”

RenX Enterprises Corp. reported financial results for twelve months ended December 31, 2023.

“Safe and Green Development Corp Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update March 28, 2024 / March 08, 2024 (GLOBE NEWSWIRE) -- Safe and Green Development Corporation (NASDAQ: SGD)(“SG DevCo” or the “Company”), today reported financial results for the twelve months ended December 31, 2023.”

SURF AIR MOBILITY INC. reported first quarter 2024 results: revenue in the range of $28.5 million to $29.5 million. Guidance initiated.

“FIRST QUARTER 2024 FINANCIAL OUTLOOK ● Revenue, in the range of $28.5 million to $29.5 million. ● Pro forma adjusted EBITDA, in the range of $(17.0) million to $(14.0) million, which excludes the expected impact of stock-based compensation, changes in fair value of financial instruments, and other non-recurring items.”

SURF AIR MOBILITY INC. reported fourth quarter ended December 31, 2023 results: revenue GAAP revenue of $26.8 million, net income GAAP Net Loss of $(110.5) million.

“GAAP revenue of $26.8 million. Pro forma revenue of $27.4 million for fourth quarter 2023, compared to $27.7 million for the same period of the prior year.”

SURF AIR MOBILITY INC. reported the year ended December 31, 2023 results: revenue GAAP revenue of $60.5 million, net income GAAP net loss of $(250.7) million.

“EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Surf Air Mobility Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2023 • Full year 2023 GAAP revenue of $60.5 million and Pro Forma revenue of $112.9 million, up 12% year-over-year, beating 2023 guidance. • Full year 2023 GAAP Net Loss of $(250.7) million and Pro Forma Net Loss of $(185.0)”

D-Wave Quantum Inc. reported financial results for fourth quarter and full year ended December 31, 2023.

“On March 28, 2024, D-Wave Quantum Inc. issued a press release announcing its financial results for the fiscal fourth quarter and full year ended December 31, 2023.”